Capstone Therapeutics Corp
OTC:CAPS

Watchlist Manager
Capstone Therapeutics Corp Logo
Capstone Therapeutics Corp
OTC:CAPS
Watchlist
Price: 0.735 USD -3.29%
Market Cap: 6.1m USD

Intrinsic Value

CAPS latest financial reports are more than 3 years old.
CAPS doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of CAPS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CAPS Intrinsic Value
Not Available
Base Case Scenario
Compare CAPS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CAPS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Capstone Therapeutics Corp

Current Assets 284k
Cash & Short-Term Investments 58k
Other Current Assets 226k
Current Liabilities 1.2m
Accounts Payable 1.2m
Accrued Liabilities 5k
Non-Current Liabilities 2.4m
Long-Term Debt 3.1m
Other Non-Current Liabilities -641k
Efficiency

Free Cash Flow Analysis
Capstone Therapeutics Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Capstone Therapeutics Corp

Revenue
0 USD
Operating Expenses
-762k USD
Operating Income
-762k USD
Other Expenses
-1.3m USD
Net Income
-2.1m USD
Fundamental Scores

CAPS Profitability Score
Profitability Due Diligence

Capstone Therapeutics Corp's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional ROE
ROIC is Increasing
60/100
Profitability
Score

Capstone Therapeutics Corp's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

CAPS Solvency Score
Solvency Due Diligence

Capstone Therapeutics Corp's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
28/100
Solvency
Score

Capstone Therapeutics Corp's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CAPS Price Targets Summary
Capstone Therapeutics Corp

Wall Street analysts forecast CAPS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAPS is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
724% Upside
Average
Price Target
6.12 USD
733% Upside
Highest
Price Target
6.3 USD
757% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Capstone Therapeutics Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for CAPS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CAPS Insider Trading
Buy and sell transactions by insiders